C 19 H 19 N 5 O 2 CdI 2 , monoclinic, P2 1 /c (no. 14), a = 12.32(1) Å,
T = 296(2) K.
CCDC no.: 1494292
The crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.
Source of material
The title complex was synthesized by reaction of N′-((quinolin-8-yl)methylene)isonicotinohydrazide (5 mmol) [6] *Corresponding author: Wei-Na Wu, College of Chemistry and Chemical Engineering, Henan Polytechnic University, Jiaozuo 454000, P.R. China, e-mail: wuwnhpu@sina.com Zhi-Hong Xu: Key Laboratory of Chemo/Biosensing and Detection, School of Chemistry and Chemical Engineering, Xuchang University, Xuchang 461000, P.R. China 
Experimental details
The hydrogen atoms were placed at calculated positions and refined as riding atoms with isotropic displacement parameters.
Discussion
Biological activities of transition metal complexes derived from Schiff base ligands are one of the most exhaustively studied topic in coordination chemistry [3] . Semicarbazone/ thiosemicarbazone derivatives of 8-formylquinoline and their metal complexes have been widely investigated [4, 5] . By contrast, their structurally analogous hydrazones and their metal complexes have been paid much less attention [6] . Therefore, the title complex was synthesized and characterized by X-ray diffraction. In the title crystal structure, the Cd(II) ion is surrounded by two iodido ligands and one [NO 2 ] donor set of the hydrazone ligand, giving a tetragonal pyramid as the basic coordination figure, with the geometric index τ being 0.260 [6] . The carbonyl bond distance of C11-O1 is 1.242(6) Å, indicating the hydrazone ligand is in a neutral form. In the solid state, intermolecular N-H· · · O hydrogen bonds between the complex and adjacent DMF molecules are present.
